Germany
Japan
United Kingdom
China
ALK mouse monoclonal antibody, clone OTI1A4
| Applications | IHC, LMNX, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Antibodies
View as table Download
.jpg?d=110x100 "User supplied image")
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
BLK Rabbit Polyclonal Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This BLK antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human BLK. |
Carrier-free (BSA/glycerol-free) PAK4 mouse monoclonal antibody, clone OTI1C7 (formerly 1C7)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Anti-PAK7 Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to C terminal 300 amino acids of human p21 protein (Cdc42/Rac)-activated kinase 7p21 protein (Cdc42/Rac)-activated kinase 7 |
Anti-CDK6 Rabbit Polyclonal Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 13-300 amino acids of Human Cyclin-dependent kinase 6 |
USD 379.00
In Stock
Active filters
Category
-
Antibodies
- Primary Antibodies
Reactivities
- Mouse
Applications
- IHC
Conjugates
- Unconjugated
Families
- Protein Kinase
Citations
- Yes
Availabilities
- In Stock
Filter by
Target Symbol
Antibody Hosts
Clonalities
Knockout (KO) Validation
Modifications
Pathways
- Pathways in cancer (22)
- MAPK signaling pathway (19)
- Focal adhesion (18)
- ErbB signaling pathway (16)
- Regulation of actin cytoskeleton (16)
- Pancreatic cancer (15)
- Prostate cancer (14)
- Non-small cell lung cancer (13)
- Endometrial cancer (12)
- Neurotrophin signaling pathway (12)
- Renal cell carcinoma (12)
- Axon guidance (11)
- Bladder cancer (11)
- Colorectal cancer (11)
- Melanoma (11)
- T cell receptor signaling pathway (11)
- Adherens junction (10)
- B cell receptor signaling pathway (10)
- Chronic myeloid leukemia (10)
- Fc epsilon RI signaling pathway (10)
- Fc gamma R-mediated phagocytosis (10)
- Glioma (10)
- VEGF signaling pathway (10)
- Chemokine signaling pathway (9)
- Endocytosis (9)
- Acute myeloid leukemia (8)
- Insulin signaling pathway (8)
- Progesterone-mediated oocyte maturation (8)
- Thyroid cancer (8)
- Toll-like receptor signaling pathway (8)
- Dorso-ventral axis formation (7)
- Gap junction (7)
- GnRH signaling pathway (7)
- Long-term depression (6)
- Long-term potentiation (6)
- Melanogenesis (6)
- Natural killer cell mediated cytotoxicity (6)
- Oocyte meiosis (6)
- Prion diseases (6)
- Vascular smooth muscle contraction (6)
- mTOR signaling pathway (6)
- TGF-beta signaling pathway (5)
- Alzheimer's disease (4)
- Apoptosis (4)
- Calcium signaling pathway (4)
- Cytokine-cytokine receptor interaction (4)
- NOD-like receptor signaling pathway (4)
- Small cell lung cancer (4)
- Type II diabetes mellitus (4)
- Jak-STAT signaling pathway (3)
- Adipocytokine signaling pathway (2)
- Epithelial cell signaling in Helicobacter pylori infection (2)
- Primary immunodeficiency (2)
- Tight junction (2)
- Cell cycle (1)
- Leukocyte transendothelial migration (1)
- p53 signaling pathway (1)